These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36076591)
1. NT157 inhibits cell proliferation and sensitizes glioma cells to TRAIL-induced apoptosis by up-regulating DR5 expression. Hou YJ; Li D; Wang W; Mao L; Fu X; Sun B; Fan C Biomed Pharmacother; 2022 Sep; 153():113502. PubMed ID: 36076591 [TBL] [Abstract][Full Text] [Related]
2. 6-Methoxydihydrosanguinarine exhibits cytotoxicity and sensitizes TRAIL-induced apoptosis of hepatocellular carcinoma cells through ROS-mediated upregulation of DR5. Wang LL; Li RT; Zang ZH; Song YX; Zhang YZ; Zhang TF; Wang FZ; Hao GP; Cao L Med Oncol; 2023 Aug; 40(9):266. PubMed ID: 37566135 [TBL] [Abstract][Full Text] [Related]
3. Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway. Cha Z; Cheng J; Xiang H; Qin J; He Y; Peng Z; Jia J; Yu H Cancer Chemother Pharmacol; 2019 Oct; 84(4):719-728. PubMed ID: 31281953 [TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. Hetschko H; Voss V; Seifert V; Prehn JH; Kögel D FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587 [TBL] [Abstract][Full Text] [Related]
6. Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Kim IY; Kang YJ; Yoon MJ; Kim EH; Kim SU; Kwon TK; Kim IA; Choi KS Neuro Oncol; 2011 Mar; 13(3):267-79. PubMed ID: 21292685 [TBL] [Abstract][Full Text] [Related]
7. Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5. Kim EY; Yu JS; Yang M; Kim AK Mol Cells; 2013 Jan; 35(1):32-40. PubMed ID: 23224239 [TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688 [TBL] [Abstract][Full Text] [Related]
10. Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5. Kang YJ; Kim IY; Kim EH; Yoon MJ; Kim SU; Kwon TK; Choi KS Exp Mol Med; 2011 Jan; 43(1):24-34. PubMed ID: 21150246 [TBL] [Abstract][Full Text] [Related]
11. Lestaurtinib potentiates TRAIL-induced apoptosis in glioma via CHOP-dependent DR5 induction. Cao Y; Kong S; Xin Y; Meng Y; Shang S; Qi Y J Cell Mol Med; 2020 Jul; 24(14):7829-7840. PubMed ID: 32441887 [TBL] [Abstract][Full Text] [Related]
12. Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice. Xu ZF; Sun XK; Lan Y; Han C; Zhang YD; Chen G Biomed Pharmacother; 2017 Nov; 95():1607-1618. PubMed ID: 28950661 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells. Ivanov VN; Zhou H; Partridge MA; Hei TK Cancer Res; 2009 Apr; 69(8):3510-9. PubMed ID: 19351839 [TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells. Yan S; Qu X; Xu C; Zhu Z; Zhang L; Xu L; Song N; Teng Y; Liu Y J Cancer Res Clin Oncol; 2012 Aug; 138(8):1279-89. PubMed ID: 22447040 [TBL] [Abstract][Full Text] [Related]
16. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation. Kim JY; Kim EH; Kim SU; Kwon TK; Choi KS Carcinogenesis; 2010 Mar; 31(3):367-75. PubMed ID: 19939880 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL. Pennarun B; Kleibeuker JH; Oenema T; Stegehuis JH; de Vries EG; de Jong S Anal Cell Pathol (Amst); 2010; 33(5):229-44. PubMed ID: 20978316 [TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines. Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587 [TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2. Min KJ; Jang JH; Lee JT; Choi KS; Kwon TK J Mol Med (Berl); 2012 Mar; 90(3):309-19. PubMed ID: 22008998 [TBL] [Abstract][Full Text] [Related]
20. Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway. Jane EP; Premkumar DR; Pollack IF Mol Cancer Ther; 2011 Jan; 10(1):198-208. PubMed ID: 21220502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]